{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:52:10Z","timestamp":1790657530476,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00277-018-03591-w","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T09:46:33Z","timestamp":1548409593000},"page":"625-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders"],"prefix":"10.1007","volume":"98","author":[{"given":"R.","family":"Borrows","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. U.","family":"Trappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"issue":"1","key":"3591_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/bjc.2013.294","volume":"109","author":"CA Clarke","year":"2013","unstructured":"Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, Weisenburger DD, Mart\u00ednez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA (2013) Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer 109(1):280\u2013288. \n                    https:\/\/doi.org\/10.1038\/bjc.2013.294","journal-title":"Br J Cancer"},{"issue":"2","key":"3591_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/leu.2008.307","volume":"23","author":"A Dispenzieri","year":"2009","unstructured":"Dispenzieri A, Kyle R, Merlini G et al (2009) International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 23(2):215\u2013224. \n                    https:\/\/doi.org\/10.1038\/leu.2008.307","journal-title":"Leukemia"},{"issue":"5","key":"3591_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2009.25.1322","volume":"28","author":"O Landgren","year":"2010","unstructured":"Landgren O, Goedert JJ, Rabkin CS, Wilson WH, Dunleavy K, Kyle RA, Katzmann JA, Rajkumar SV, Engels EA (2010) Circulating serum free light chains as predictive markers of AIDS-related lymphoma. J Clin Oncol 28(5):773\u2013779. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.25.1322","journal-title":"J Clin Oncol"},{"issue":"5","key":"3591_CR4","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/j.1600-6143.2011.03954.x","volume":"12","author":"EA Engels","year":"2012","unstructured":"Engels EA, Preiksaitis J, Zingone A, Landgren O (2012) Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder. Am J Transplant 12(5):1268\u20131274. \n                    https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03954.x","journal-title":"Am J Transplant"},{"issue":"10","key":"3591_CR5","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3109\/10428194.2013.764423","volume":"54","author":"RC Fernando","year":"2013","unstructured":"Fernando RC, Rizzatti EG, Braga WMT, Santos MG, de Oliveira MB, Pestana JOM, Baiocchi OCG, Colleoni GWB (2013) Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant. Leuk Lymphoma 54(10):2177\u20132180. \n                    https:\/\/doi.org\/10.3109\/10428194.2013.764423","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"3591_CR6","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.2215\/CJN.02290508","volume":"3","author":"CA Hutchison","year":"2008","unstructured":"Hutchison CA, Harding S, Hewins P, Mead GP, Townsend J, Bradwell AR, Cockwell P (2008) Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Clin J Am Soc Nephrol 3(6):1684\u20131690. \n                    https:\/\/doi.org\/10.2215\/CJN.02290508","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"3591_CR7","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3109\/10428194.2013.767456","volume":"54","author":"F Jardin","year":"2013","unstructured":"Jardin F, Delfau-Larue MH, Molina TJ, Copie-Bergman C, Bri\u00e8re J, Petrella T, Canioni D, Fabiani B, Jais JP, Figeac M, Leroy K, Mareschal S, Salles GA, Coiffier B, Delarue R, Peyrade F, Bosly A, Andr\u00e9 M, Ketterer N, Haioun C, Tilly H (2013) Immunoglobulin heavy chain\/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma. Leuk Lymphoma 54(9):1898\u20131907. \n                    https:\/\/doi.org\/10.3109\/10428194.2013.767456","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"3591_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/leu.2012.159","volume":"27","author":"A Bradwell","year":"2013","unstructured":"Bradwell A, Harding S, Fourrier N, Mathiot C, Attal M, Moreau P, Harousseau JL, Avet-Loiseau H (2013) Prognostic utility of intact immunoglobulin Ig'\u03ba\/Ig'\u03bb ratios in multiple myeloma patients. Leukemia 27(1):202\u2013207. \n                    https:\/\/doi.org\/10.1038\/leu.2012.159","journal-title":"Leukemia"},{"issue":"2","key":"3591_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","volume":"13","author":"R Trappe","year":"2012","unstructured":"Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Salles G, Morschhauser F, Jaccard A, Lamy T, Leith\u00e4user M, Zimmermann H, Anagnostopoulos I, Raphael M, Riess H, Choquet S (2012) Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD). The prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol 13(2):196\u2013206. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(11)70300-X","journal-title":"Lancet Oncol"},{"issue":"5","key":"3591_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1200\/JCO.2016.69.3564","volume":"35","author":"RU Trappe","year":"2017","unstructured":"Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, D\u00fchrsen U, Reinke P, Verhoef G, Subklewe M, H\u00fcttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, van den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S (2017) Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP consolidation in an international, prospective, Multicenter Phase II Trial. J Clin Oncol 35(5):536\u2013543. \n                    https:\/\/doi.org\/10.1200\/JCO.2016.69.3564","journal-title":"J Clin Oncol"},{"key":"3591_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1182\/asheducation-2013.1.95","volume":"2013","author":"H Zimmermann","year":"2013","unstructured":"Zimmermann H, Trappe RU (2013) EBV and posttransplantation lymphoproliferative disease: what to do? Hematology Am Soc Hematol Educ Program 2013:95\u2013102. \n                    https:\/\/doi.org\/10.1182\/asheducation-2013.1.95","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"9","key":"3591_CR12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","volume":"48","author":"JA Katzmann","year":"2002","unstructured":"Katzmann JA, Clark RJ, Abraham RS et al (2002) Serum reference intervals and diagnostic ranges for free \u03ba and free \u03bb immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 48(9):1437\u20131444","journal-title":"Clin Chem"},{"issue":"7","key":"3591_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3324\/haematol.2010.039214","volume":"96","author":"R Trappe","year":"2011","unstructured":"Trappe R, Zimmermann H, Fink S, Reinke P, Dreyling M, Pascher A, Lehmkuhl H, Gartner B, Anagnostopoulos I, Riess H (2011) Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases. Haematologica 96(7):1067\u20131071. \n                    https:\/\/doi.org\/10.3324\/haematol.2010.039214","journal-title":"Haematologica"},{"issue":"16\u201317","key":"3591_CR14","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.clinbiochem.2013.08.024","volume":"46","author":"A-S Bargnoux","year":"2013","unstructured":"Bargnoux A-S, Simon N, Garrigue V, Dupuy AM, Badiou S, Mourad G, Cristol JP (2013) Glomerular filtration rate as a determinant of free light chains in renal transplantation. Clin Biochem 46(16\u201317):1764\u20131766. \n                    https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.08.024","journal-title":"Clin Biochem"},{"issue":"4","key":"3591_CR15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","volume":"47","author":"AR Bradwell","year":"2001","unstructured":"Bradwell AR, Carr-Smith HD, Mead GP et al (2001) Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 47(4):673\u2013680","journal-title":"Clin Chem"},{"issue":"6","key":"3591_CR16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1309\/AJCP4INKZ6LYAQXW","volume":"137","author":"KM Charafeddine","year":"2012","unstructured":"Charafeddine KM, Jabbour MN, Kadi RH, Daher RT (2012) Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review. Am J Clin Pathol 137(6):890\u2013897. \n                    https:\/\/doi.org\/10.1309\/AJCP4INKZ6LYAQXW","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"3591_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1021\/pr100729z","volume":"10","author":"E Vendrame","year":"2011","unstructured":"Vendrame E, Mart\u00ednez-Maza O (2011) Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma. J Proteome Res 10(1):113\u2013119. \n                    https:\/\/doi.org\/10.1021\/pr100729z","journal-title":"J Proteome Res"},{"issue":"9356","key":"3591_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(03)12457-9","volume":"361","author":"AR Bradwell","year":"2003","unstructured":"Bradwell AR, Carr-Smith HD, Mead GP, Harvey TC, Drayson MT (2003) Serum test for assessment of patients with Bence Jones myeloma. Lancet 361(9356):489\u2013491. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(03)12457-9","journal-title":"Lancet"},{"issue":"10","key":"3591_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1373\/clinchem.2011.169433","volume":"57","author":"CA Hutchison","year":"2011","unstructured":"Hutchison CA, Landgren O (2011) Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation. Clin Chem 57(10):1387\u20131389. \n                    https:\/\/doi.org\/10.1373\/clinchem.2011.169433","journal-title":"Clin Chem"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-03591-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-03591-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-03591-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T00:16:32Z","timestamp":1579911392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-03591-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3591"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-03591-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]},"assertion":[{"value":"11 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was provided by the local committees of both institutions. The study was conducted according to the guidelines of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The Binding Site provided FLC, HLC and cystatin C assays free of charge. The Binding Site played no role in the analysis of the clinical data, its interpretation or the manuscript preparation. The content of the manuscript remains the responsibility of the listed authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}